These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 35777218)

  • 1. CRISPR/Cas-engineered technology: Innovative approach for biosensor development.
    Zavvar TS; Khoshbin Z; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
    Biosens Bioelectron; 2022 Oct; 214():114501. PubMed ID: 35777218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas-based Aptasensor as an Innovative Sensing Approaches for Food Safety Analysis: Recent Progresses and New Horizons.
    Suliman Maashi M
    Crit Rev Anal Chem; 2024; 54(7):2599-2617. PubMed ID: 36940173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold Nanomaterials-Implemented CRISPR-Cas Systems for Biosensing.
    Fu R; Xianyu Y
    Small; 2023 May; 19(21):e2300057. PubMed ID: 36840654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas12a System for Biosensing and Gene Regulation.
    Shi Y; Fu X; Yin Y; Peng F; Yin X; Ke G; Zhang X
    Chem Asian J; 2021 Apr; 16(8):857-867. PubMed ID: 33638271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating CRISPR-Cas12a with a crRNA-Mediated Catalytic Network for the Development of a Modular and Sensitive Aptasensor.
    Shu X; Zhang D; Li X; Zheng Q; Cai X; Ding S; Yan Y
    ACS Synth Biol; 2022 Aug; 11(8):2829-2836. PubMed ID: 35946354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-Generation Diagnostic with CRISPR/Cas: Beyond Nucleic Acid Detection.
    Bhardwaj P; Kant R; Behera SP; Dwivedi GR; Singh R
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamer assisted CRISPR-Cas12a strategy for small molecule diagnostics.
    Niu C; Wang C; Li F; Zheng X; Xing X; Zhang C
    Biosens Bioelectron; 2021 Jul; 183():113196. PubMed ID: 33839534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches.
    Ahmed MZ; Badani P; Reddy R; Mishra G
    J Mol Diagn; 2021 Nov; 23(11):1433-1442. PubMed ID: 34454111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying biosensor development concepts to improve preamplification-free CRISPR/Cas12a-Dx.
    Hsieh K; Zhao G; Wang TH
    Analyst; 2020 Jul; 145(14):4880-4888. PubMed ID: 32478351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNase H-Driven crRNA Switch Circuits for Rapid and Sensitive Detection of Various Analytical Targets.
    Li HD; Fang GH; Ye BC; Yin BC
    Anal Chem; 2023 Dec; 95(50):18549-18556. PubMed ID: 38073045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point-of-care CRISPR/Cas nucleic acid detection: Recent advances, challenges and opportunities.
    van Dongen JE; Berendsen JTW; Steenbergen RDM; Wolthuis RMF; Eijkel JCT; Segerink LI
    Biosens Bioelectron; 2020 Oct; 166():112445. PubMed ID: 32758911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing the power of clustered regularly interspaced short palindromic repeats (CRISPR) based microfluidics for next-generation molecular diagnostics.
    Kaur R; Gupta S; Chauhan A; Mishra V; Sharma MK; Singh J
    Mol Biol Rep; 2024 Aug; 51(1):896. PubMed ID: 39115550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of CRISPR/Cas-based biosensors for detecting nucleic acid of pathogens].
    Liu T; Tian Y; Liu C; Fang S; Wu Y; Wu M; Li B; Yang H; Liu Q
    Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3890-3904. PubMed ID: 34841793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the trans-cleavage activity of CRISPR-Cas12a for the development of a Mxene based electrochemiluminescence biosensor for the detection of Siglec-5.
    Zhang K; Fan Z; Yao B; Ding Y; Zhao J; Xie M; Pan J
    Biosens Bioelectron; 2021 Apr; 178():113019. PubMed ID: 33517231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancements of CRISPR technology in public health-related analysis.
    Gu X; Tang Q; Zhu Y; Sun C; Wu L; Ji H; Wang Q; Wu L; Qin Y
    Biosens Bioelectron; 2024 Oct; 261():116449. PubMed ID: 38850734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorothioate-modified G-quadruplex as a signal-on dual-mode reporter for CRISPR/Cas12a-based portable detection of environmental pollutants.
    Shi K; Tian Y; Liu S; Luo W; Liu K; Zhang L; Zhang Y; Chang J; Zhang J; Wang S
    Anal Chim Acta; 2024 Jun; 1308():342649. PubMed ID: 38740457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas and Argonaute-Based Biosensors for Pathogen Detection.
    Yang Z; Mao S; Wang L; Fu S; Dong Y; Jaffrezic-Renault N; Guo Z
    ACS Sens; 2023 Oct; 8(10):3623-3642. PubMed ID: 37819690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Installing CRISPR-Cas12a sensors in a portable glucose meter for point-of-care detection of analytes.
    Liu R; He Y; Lan T; Zhang J
    Analyst; 2021 May; 146(10):3114-3120. PubMed ID: 33999055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleic Acid Enzyme-Activated CRISPR-Cas12a With Circular CRISPR RNA for Biosensing.
    Wu Y; Chang D; Chang Y; Zhang Q; Liu Y; Brennan JD; Li Y; Liu M
    Small; 2023 Oct; 19(41):e2303007. PubMed ID: 37294164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas12a-Enabled Multiplex Biosensing Strategy Via an Affordable and Visual Nylon Membrane Readout.
    Hu T; Ke X; Li W; Lin Y; Liang A; Ou Y; Chen C
    Adv Sci (Weinh); 2023 Jan; 10(2):e2204689. PubMed ID: 36442853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.